Oruka Therapeutics, Inc.

ORKA·NASDAQ·$59.06Share Price as of 11/2·$2BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/10/26 10-QQ1 ended 03/31/2605/13/26 10-KFY 202503/12/26 10-QQ3 ended 09/30/2511/12/25 10-QQ2 ended 06/30/2508/11/25

Disclosures

8-KCurrent report10/26/26 8-KCurrent report08/24/26 8-KCurrent report08/10/26 8-KCurrent report06/04/26 8-KCurrent report06/01/26

Prospectuses and Registrations

424B5Prospectus supplement08/28/26 S-3Shelf registration08/21/26 424B5Prospectus supplement04/29/26 424B5Prospectus supplement04/27/26 424B5Prospectus supplement04/27/26

Proxies

DEF 14ADefinitive proxy04/17/26 DEFA14AAdditional proxy materials04/17/26 DEF 14ADefinitive proxy04/18/25 DEFA14AAdditional proxy materials04/18/25 DEF 14ADefinitive proxy10/18/24

Ownership

Form 4Insider transaction10/20/26 144Proposed sale of securities10/15/26 Form 4Insider transaction10/15/26 144Proposed sale of securities10/13/26 Form 4Insider transaction10/13/26

Other

EFFECTRequest for effectiveness08/27/26 ARSAnnual report to shareholders04/17/26 EFFECTRequest for effectiveness04/10/26 CORRESPCorrespondence with the SEC04/08/26 UPLOADLetter from the SEC04/07/26